CYP2C19 status and risk of major adverse cardiovascular events in peripheral artery disease: Insights from the EUCLID Trial.

Journal Article (Letter;Multicenter Study)

Full Text

Duke Authors

Cited Authors

  • Gutierrez, JA; Heizer, GM; Jones, WS; Rockhold, FW; Mahaffey, KW; Fowkes, FGR; Berger, JS; Baumgartner, I; Held, P; Katona, BG; Norgren, L; Blomster, JI; Hiatt, WR; Patel, MR

Published Date

  • November 2020

Published In

Volume / Issue

  • 229 /

Start / End Page

  • 118 - 120

PubMed ID

  • 32950849

Electronic International Standard Serial Number (EISSN)

  • 1097-6744

Digital Object Identifier (DOI)

  • 10.1016/j.ahj.2020.07.017


  • eng

Conference Location

  • United States